“…Moreover, TIMP1 is secreted into the plasma in certain fibrosing diseases and cancers and, therefore, affects distant tissues in a manner analogous to an endocrine factor. Consistent with this notion, TIMP1 is highly induced during fibrosis in a number of animal models, such as bleomycin- and paraquat-induced lung fibrosis, and fibrosing diseases in humans, such as IPF and liver cirrhosis, implicating dysregulation of TIMP1 expression in the development of fibrosis (Dong et al, 2016; Hayashi et al, 1996; Madtes et al, 2001; Manoury et al, 2006; Selman et al, 2000; Tomita et al, 2007). Nonetheless, the function of TIMP1 in fibrosis, in particular, in the development of lung fibrosis remains largely unclear.…”